- Home
- ONFO vs CDT Comparison
ONFO vs CDT Comparison
Compare ONFO & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- CDT
- Stock Information
- Founded
- ONFO 2018
- CDT 2019
- Country
- ONFO United States
- CDT United States
- Employees
- ONFO N/A
- CDT N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- CDT Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- CDT Health Care
- Exchange
- ONFO Nasdaq
- CDT Nasdaq
- Market Cap
- ONFO 5.4M
- CDT 5.2M
- IPO Year
- ONFO 2022
- CDT N/A
- Fundamental
- Price
- ONFO $1.04
- CDT $1.64
- Analyst Decision
- ONFO
- CDT
- Analyst Count
- ONFO 0
- CDT 0
- Target Price
- ONFO N/A
- CDT N/A
- AVG Volume (30 Days)
- ONFO 57.3K
- CDT 95.0K
- Earning Date
- ONFO 08-14-2025
- CDT 08-26-2025
- Dividend Yield
- ONFO N/A
- CDT N/A
- EPS Growth
- ONFO N/A
- CDT N/A
- EPS
- ONFO N/A
- CDT N/A
- Revenue
- ONFO $10,508,728.00
- CDT N/A
- Revenue This Year
- ONFO N/A
- CDT N/A
- Revenue Next Year
- ONFO N/A
- CDT N/A
- P/E Ratio
- ONFO N/A
- CDT N/A
- Revenue Growth
- ONFO 78.36
- CDT N/A
- 52 Week Low
- ONFO $0.61
- CDT $1.61
- 52 Week High
- ONFO $1.88
- CDT $274.80
- Technical
- Relative Strength Index (RSI)
- ONFO 45.84
- CDT 29.41
- Support Level
- ONFO $0.94
- CDT $1.66
- Resistance Level
- ONFO $1.26
- CDT $1.85
- Average True Range (ATR)
- ONFO 0.11
- CDT 0.11
- MACD
- ONFO -0.02
- CDT 0.03
- Stochastic Oscillator
- ONFO 27.75
- CDT 8.36
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.